Food News and Research

RSS

BSD provides additional information to FDA for 510(k) submission of MicroThermX Microwave Ablation System

BSD Medical Corporation today announced that it has provided the additional information requested by the U.S. Food and Drug Administration (FDA) for review of the 510(k) submission the Company filed for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System (MTX-180) for ablation of soft tissue.

22 Jul 2010

Stop & Shop offers high quality, fresh from farm produce

Ice cream and popsicles aren't the only treats to offer kids after a long day of fun in the sun. With an abundance of in season fruits and veggies, Summer is the perfect time to instill healthy eating habits. Thanks to Stop & Shop's 6oyears partnership with local farmers, shoppers can purchase high quality, fresh from the farm produce.

22 Jul 2010

Current myths vs. realities in global AIDS funding

Activists at the International AIDS Conference in Vienna are charging developed and developing country governments with writing checques that bounce to the millions of people in need of lifesaving HIV treatment. Despite the gains in treatment numbers reported by WHO, the International Treatment Preparedness Coalition's (ITPC), latest report, Rationing Funds, Risking Lives, documents early warnings of the global pullback on AIDS commitment and funding.

22 Jul 2010

Canon Communications to redesign NutritionalOutlook for quick access to relevant content

Today, at the IFT Annual Meeting and Food Expo, the largest annual food science forum and exposition in the world, Canon Communications LLC announced it is in the process of a redesign of NutritionalOutlook.com, the leading online resource for manufacturers of dietary supplements and healthy foods. The website redesign, featuring new content, qualified supplier search, community-building tools, and nutraceutical industry resources, will launch in fall 2010.

22 Jul 2010

Call for American manufacturers to include medicinal ingredients from around the globe in foods, beverages

As consumers overseas embrace foods and beverages made with ingredients long known to have health and wellness benefits, American manufacturers can take a cue from their success and add such medicinal ingredients to their foods and beverages, according to a scientific discussion at the 2010 Institute of Food Technologists (IFT) Annual Meeting and Food Expo®.

22 Jul 2010

Survey links autism with digestive problems, intestinal inflammation

Autism is the fastest growing developmental disorder in the world. With 1 child in 91 facing the disorder, the diagnosis is more common than pediatric cancer, diabetes, and AIDS combined.

22 Jul 2010

Caraco Pharmaceutical Laboratories begins marketing bupropion hydrochloride extended release tablets

Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SR® Extended Release tablets.

22 Jul 2010

Also in Global Health News: India's food security; ASEAN to address disaster preparedness; Iraqi food aid; Why fistula plagues Kenya

A Reuters article discusses the implications of an Indian bill that would "subsidise grains for the poor, a move that will impact government finances as well as political support." According to the news service, the proposal "aims to partly shield a substantial voter base from surging inflation in a country where about 40 percent of the 1.2 billion population lives below the U.N. estimated poverty line."

22 Jul 2010

Actavis Group receives FDA approval to market Bupropion HCl SR tablets

Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Bupropion HCl Extended-Release tablets 100mg and 200mg. Distribution of the product will commence immediately.

22 Jul 2010

Avastin – breast cancer drug, fails to pass the FDA advisory panel vote on efficacy

According to a Food and Drug Administration (FDA) advisory committee’s (The Oncology Drugs Advisory Committee, or ODAC) recommendation this Tuesday, the marketing approval of the popular breast cancer drug, Avastin or Bevacizumab should be withdrawn.

21 Jul 2010

SensAble Technologies reports record dental sales for second-quarter 2010

SensAble Technologies Inc., a privately held provider of 3D modeling software, haptic devices and dental restoration design and fabrication solutions, announced that it achieved record dental sales during its second quarter ending June 30, driven by worldwide popularity of its integrated SensAble Dental Lab System (SDLS).

21 Jul 2010

AMRI initiates enrollment for Phase I study of ALB-127158 for obesity

AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.

21 Jul 2010

SPX announces completion of Anhydro acquisition

SPX Corporation today announced that it has completed the acquisition of the Anhydro business, a Soeborg, Denmark-based global supplier of liquid concentration equipment, powder processing solutions, and dewatering plants and equipment. The terms of the transaction were not disclosed.

21 Jul 2010

NovaBay reports positive results from NVC-422 Phase 2a proof-of-concept clinical trial for impetigo

NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.

21 Jul 2010

Burger King to offer breakfast meal that meets BKC's stringent nutrition criteria

Today Burger King Corp. announced it will offer a breakfast meal for children that meets BKC's stringent nutrition criteria for advertised Kids Meals, as defined in its pledge through the Council of Better Business Bureau's Children's Food and Beverage Advertising Initiative.

21 Jul 2010

CAP calls for increased FDA oversight of laboratory developed and 'direct-to-consumer' tests

With the increasing importance of laboratory tests in diagnosing and treating disease, representatives of the College of American Pathologists (CAP) today presented recommendations to the Food and Drug Administration (FDA) urging increased oversight of laboratory developed tests (LDTs) and "direct-to-consumer" tests. Most genetic tests fall into one or both of these testing categories.

21 Jul 2010

AMP particpates at FDA's public meeting on oversight of laboratory developed tests

The Association for Molecular Pathology participated in the Food and Drug Administration Center for Devices and Radiological Health public meeting on the oversight of laboratory developed tests. Dr. Karen Mann, President of AMP, served on the second panel of the meeting titled, Clinical Laboratory Challenges. Additionally, Dr. Elaine Lyon, Chair of the AMP Professional Relations Committee, presented public comments. "AMP believes that LDTs are an essential and central component of medical practice," said Dr. Lyon, "Without LDTs, the practice of medicine that we know today would be severely reduced in scope."

21 Jul 2010

Zimmer sued over defective hip implant

Wendy R. Fleishman, a partner in the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that William Kokoszka filed a personal injury lawsuit against Zimmer Inc., the nation's largest producer of orthopedic devices. Following his 2006 hip replacement, Kokoszka suffered constant and devastating pain for over 18 months before having to undergo a second hip replacement surgery due to an allegedly defective hip implant manufactured and sold by Zimmer under the brand name Durom Cup.

21 Jul 2010

ACS to hold symposium on Deepwater Horizon oil spill

The American Chemical Society (ACS) will hold a special day-long symposium on the Deepwater Horizon oil spill on Tuesday, Aug. 24 during its National Meeting & Exposition here. The symposium, which includes almost a dozen experts, will examine topics ranging from the spill's effects on marine life to its effects on the safety of seafood. It will take place from 8 a.m. to 4 p.m. in Room 210C of the Boston Convention and Exhibition Center, followed by an open-discussion session from 4:30 p.m. to 6 p.m.

21 Jul 2010

AIDS 2010: Study finds microbicide containing HIV drug lowers infection risk in women by 39%

A microbicide gel containing Gilead's HIV drug tenofovir used by women before and after sex has been shown to reduce their risk of HIV infection by nearly 40%, according to a study unveiled at the International AIDS Conference-AIDS 2010, Reuters reports

21 Jul 2010

Food News and Research

BSD provides additional information to FDA for 510(k) submission of MicroThermX Microwave Ablation System

Stop & Shop offers high quality, fresh from farm produce

Current myths vs. realities in global AIDS funding

Canon Communications to redesign NutritionalOutlook for quick access to relevant content

Call for American manufacturers to include medicinal ingredients from around the globe in foods, beverages

Survey links autism with digestive problems, intestinal inflammation

Caraco Pharmaceutical Laboratories begins marketing bupropion hydrochloride extended release tablets

Also in Global Health News: India's food security; ASEAN to address disaster preparedness; Iraqi food aid; Why fistula plagues Kenya

Actavis Group receives FDA approval to market Bupropion HCl SR tablets

Avastin – breast cancer drug, fails to pass the FDA advisory panel vote on efficacy

SensAble Technologies reports record dental sales for second-quarter 2010

AMRI initiates enrollment for Phase I study of ALB-127158 for obesity

SPX announces completion of Anhydro acquisition

NovaBay reports positive results from NVC-422 Phase 2a proof-of-concept clinical trial for impetigo

Burger King to offer breakfast meal that meets BKC's stringent nutrition criteria

CAP calls for increased FDA oversight of laboratory developed and 'direct-to-consumer' tests

AMP particpates at FDA's public meeting on oversight of laboratory developed tests

Zimmer sued over defective hip implant

ACS to hold symposium on Deepwater Horizon oil spill

AIDS 2010: Study finds microbicide containing HIV drug lowers infection risk in women by 39%

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News